These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8171639)

  • 1. Prolongation of allograft survival with Ling Zhi-8, a new immunosuppressive drug.
    van der Hem LG; van der Vliet JA; Bocken CF; Kino K; Hoitsma AJ; Tax WJ
    Transplant Proc; 1994 Apr; 26(2):746. PubMed ID: 8171639
    [No Abstract]   [Full Text] [Related]  

  • 2. Ling-Zhi-8: a fungal protein with immunomodulatory effects.
    van der Hem LG; van der Vliet JA; Kino K; Hoitsma AJ; Tax WJ
    Transplant Proc; 1996 Apr; 28(2):958-9. PubMed ID: 8623480
    [No Abstract]   [Full Text] [Related]  

  • 3. Toward a new device for islet cell immunoisolation in pancreatic transplantation.
    van der Vliet JA; Bonthuis F; Marquet RL; Feyen J
    Transplant Proc; 1992 Jun; 24(3):955. PubMed ID: 1604682
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term survival of Wistar-Furth islet allografts in Lewis rats is associated with spontaneously tolerated orthotopic liver allografts.
    Wan X; Yu W; Yang H; al-Abdullah I; Coddington D; Bitter-Suermann H; Wright JR
    Transplant Proc; 1994 Apr; 26(2):723-4. PubMed ID: 8171625
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of immune rejection in rat islet allografts by continuous SC administration of FK 506 using a mini-osmotic pump.
    Ryu S; Yasunami Y
    Transplant Proc; 1991 Feb; 23(1 Pt 1):760. PubMed ID: 1703710
    [No Abstract]   [Full Text] [Related]  

  • 6. Microencapsulated transplantation of allogeneic islets into specifically presensitized recipients.
    Siebers U; Zekorn T; Horcher A; Klöck G; Houben R; Frank H; Bretzel RG; Zimmermann U; Federlin K
    Transplant Proc; 1994 Apr; 26(2):787-8. PubMed ID: 8171662
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of islet allografts by pretreatment with intrathymic UV-B donor spleen cells.
    Jin MX; Chowdhury NC; James T; Engelstad K; Hardy MA; Oluwole SF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):291. PubMed ID: 8438304
    [No Abstract]   [Full Text] [Related]  

  • 8. Permanent acceptance of mitomycin C-treated islet allograft.
    Matsuyama S; Gunji T; Ise K; Sato Y; Saito T; Gotoh M
    Transplantation; 2003 Jul; 76(1):65-71. PubMed ID: 12865788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two new DNA synthesis inhibitors with potent immunosuppressive activity prolong allograft and xenograft survival in small and large animals.
    Goodman ER; Fiedor PS; Fein S; Sung RS; Athan E; Hardy MA
    Transplant Proc; 1996 Apr; 28(2):920-1. PubMed ID: 8623463
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
    Rastellini C; Cicalese L; Leach R; Braun M; Fung JJ; Starzl TE; Rao AS
    Transplant Proc; 1999; 31(1-2):646-7. PubMed ID: 10083278
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of the immunosuppressive activity of FK 506 in rat islet allografts.
    Yasunami Y; Ryu S; Kamei T
    Transplant Proc; 1990 Apr; 22(2):875. PubMed ID: 1691557
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.
    Desai NM; Bassiri H; Odorico JS; Koller BH; Smithies O; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1993 Feb; 25(1 Pt 2):961-2. PubMed ID: 8442280
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular requirements for pancreatic islet xenograft rejection.
    Ahn M; Chang E; Chu G; Barker CF; Markmann JF
    Transplant Proc; 1995 Dec; 27(6):3302-3. PubMed ID: 8539963
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity of peripheral lymphocytes as a new approach to early diagnosis of ongoing allograft rejection.
    Kuttler B; Wanka H; Hahn HJ
    Transplant Proc; 1994 Apr; 26(2):730-1. PubMed ID: 8171629
    [No Abstract]   [Full Text] [Related]  

  • 15. Potent immunosuppressive effect of anti-LFA-1 monoclonal antibody on islet allograft rejection.
    Nishihara M; Gotoh M; Fukuzaki T; Ohta Y; Monden M; Yagita H; Okumura K; Miyasaka M; Mori T
    Transplant Proc; 1995 Feb; 27(1):372. PubMed ID: 7879025
    [No Abstract]   [Full Text] [Related]  

  • 16. Islet xenografts in mice and rats: I. Exocrine tissue is detrimental to engraftment and survival of human islet xenografts.
    Nicolae M; Ketchum RJ; Jahr H; Janoff H; Brayman KL
    Transplant Proc; 1994 Apr; 26(2):774. PubMed ID: 8171657
    [No Abstract]   [Full Text] [Related]  

  • 17. Acceptance of donor-specific islet allografts in rat by intraportal preimmunization with islets and FK 506.
    Yasunami Y; Ryu S; Ueki M; Arima T; Ikeda S; Kamei T
    Transplant Proc; 1994 Apr; 26(2):722. PubMed ID: 7513467
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of direct and indirect antigen presentation in the response to islet xenografts.
    Gill RG
    Transplant Proc; 1992 Apr; 24(2):642-3. PubMed ID: 1533075
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody.
    Osorio RW; Ascher NL; Melzer JS; Stock PG
    Transplant Proc; 1994 Apr; 26(2):749. PubMed ID: 8171642
    [No Abstract]   [Full Text] [Related]  

  • 20. Ling Zhi-8: studies of a new immunomodulating agent.
    van der Hem LG; van der Vliet JA; Bocken CF; Kino K; Hoitsma AJ; Tax WJ
    Transplantation; 1995 Sep; 60(5):438-43. PubMed ID: 7676490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.